• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国南京人群 2 型糖尿病患者五年心血管疾病风险预测:来自中国南京的推导和英国苏格兰的外部验证。

Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK.

机构信息

Department of Medical Informatic, School of Biomedical Engineering and Informatics, Nanjing Medical University, CN.

Women's College Research Institute, Women's College Hospital, Toronto, CA.

出版信息

Glob Heart. 2022 Jul 28;17(1):46. doi: 10.5334/gh.1131. eCollection 2022.

DOI:10.5334/gh.1131
PMID:36051323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9336685/
Abstract

BACKGROUND

To use routinely collected data to develop a five-year cardiovascular disease (CVD) risk prediction model for Chinese adults with type 2 diabetes with validation of its performance in a population of European ancestry.

METHODS

People with incident type 2 diabetes and no history of CVD at diagnosis of diabetes between 2008 and 2017 were included in derivation and validation cohorts. The derivation cohort was identified from a pseudonymized research extract of data from the First Affiliated Hospital of Nanjing Medical University (NMU). Five-year risk of CVD was estimated using basic and extended Cox proportional hazards regression models including 6 and 11 predictors respectively. The risk prediction models were internally validated and externally validated in a Scottish population-based cohort with CVD events identified from linked hospital records. Discrimination and calibration were assessed using Harrell's C-statistic and calibration plots, respectively.

RESULTS

Mean age of the derivation and validation cohorts were 58.4 and 59.2 years, respectively, with 53.5% and 56.9% men. During a median follow-up time of 4.75 [2.67, 7.42] years, 18,827 (22.25%) of the 84,630 people in the NMU-Diabetes cohort and 8,763 (7.31%) of the Scottish cohort of 119,891 people developed CVD. The extended model had a C-statistic of 0.723 [0.721-0.724] in internal validation and 0.716 [0.713-0.719] in external validation.

CONCLUSIONS

It is possible to generate a risk prediction model with moderate discriminative power in internal and external validation derived from routinely collected Chinese hospital data. The proposed risk score could be used to improve CVD prevention in people with diabetes.

摘要

背景

利用常规收集的数据为中国成年 2 型糖尿病患者建立一个 5 年心血管疾病(CVD)风险预测模型,并在欧洲人群中验证其性能。

方法

纳入了 2008 年至 2017 年间诊断为 2 型糖尿病且无 CVD 病史的患者。推导队列来自南京医科大学第一附属医院(NMU)的匿名研究数据摘录。使用包括 6 个和 11 个预测因子的基本和扩展 Cox 比例风险回归模型来估计 CVD 风险。使用来自链接医院记录的苏格兰人群队列中的 CVD 事件来对风险预测模型进行内部验证和外部验证。使用 Harrell 的 C 统计量和校准图分别评估区分度和校准度。

结果

推导和验证队列的平均年龄分别为 58.4 岁和 59.2 岁,分别有 53.5%和 56.9%的男性。在中位数为 4.75 年[2.67 年至 7.42 年]的随访期间,在 NMU-Diabetes 队列的 84630 人中,有 18827 人(22.25%)发生了 CVD,在苏格兰队列的 119891 人中,有 8763 人(7.31%)发生了 CVD。扩展模型在内部验证中的 C 统计量为 0.723[0.721-0.724],在外部验证中的 C 统计量为 0.716[0.713-0.719]。

结论

从常规收集的中国医院数据中推导和验证,有可能生成具有中等区分能力的风险预测模型。该风险评分可用于改善糖尿病患者的 CVD 预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb0/9336685/55cbbdb10d38/gh-17-1-1131-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb0/9336685/8212e23e150a/gh-17-1-1131-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb0/9336685/55cbbdb10d38/gh-17-1-1131-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb0/9336685/8212e23e150a/gh-17-1-1131-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb0/9336685/55cbbdb10d38/gh-17-1-1131-g2.jpg

相似文献

1
Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK.中国南京人群 2 型糖尿病患者五年心血管疾病风险预测:来自中国南京的推导和英国苏格兰的外部验证。
Glob Heart. 2022 Jul 28;17(1):46. doi: 10.5334/gh.1131. eCollection 2022.
2
Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.心血管疾病风险评分在诊断为 2 型糖尿病的人群中的表现:利用苏格兰国家糖尿病登记处的数据进行外部验证。
Diabetes Care. 2018 Sep;41(9):2010-2018. doi: 10.2337/dc18-0578. Epub 2018 Jul 12.
3
Development and validation of 10-year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning-based methods.应用基于可解释机器学习的方法建立并验证中国基层医疗机构 2 型糖尿病患者心血管疾病 10 年风险预测模型。
Diabetes Obes Metab. 2024 Sep;26(9):3969-3987. doi: 10.1111/dom.15745. Epub 2024 Jul 15.
4
Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.用于估计2型糖尿病未来风险的QDiabetes-2018风险预测算法的开发与验证:队列研究
BMJ. 2017 Nov 20;359:j5019. doi: 10.1136/bmj.j5019.
5
Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.预测肺癌未来风险:CanPredict(肺部)模型在 1967 万人中的开发、内部和外部验证以及该模型与其他七个风险预测模型的性能评估。
Lancet Respir Med. 2023 Aug;11(8):685-697. doi: 10.1016/S2213-2600(23)00050-4. Epub 2023 Apr 5.
6
Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.基于人群的回顾性队列研究:为中国 2 型糖尿病患者开发心血管疾病风险预测模型和工具。
Diabetes Obes Metab. 2018 Feb;20(2):309-318. doi: 10.1111/dom.13066. Epub 2017 Aug 25.
7
Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model.已确诊心血管疾病患者2型糖尿病发病终生预测模型的开发与验证:CVD2DM模型
Eur J Prev Cardiol. 2024 Oct 10;31(14):1671-1678. doi: 10.1093/eurjpc/zwae096.
8
Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study.糖尿病患者失明和下肢截肢未来风险预测方程的开发与验证:队列研究
BMJ. 2015 Nov 11;351:h5441. doi: 10.1136/bmj.h5441.
9
Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study.基于 2 型糖尿病合并糖尿病肾病患者的前瞻性队列研究,推导并外部验证了一种用于估计心血管死亡未来风险的风险预测算法。
BMJ Open Diabetes Res Care. 2019 Nov 13;7(1):e000735. doi: 10.1136/bmjdrc-2019-000735. eCollection 2019.
10
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.1 型糖尿病患者的寿命和 10 年心血管风险预测:LIFE-T1D 模型。
Diabetes Obes Metab. 2024 Jun;26(6):2229-2238. doi: 10.1111/dom.15531. Epub 2024 Mar 8.

引用本文的文献

1
Overcoming Missing Data: Accurately Predicting Cardiovascular Risk in Type 2 Diabetes, A Systematic Review.克服数据缺失:2型糖尿病心血管风险的准确预测,一项系统评价
J Diabetes. 2025 Jan;17(1):e70049. doi: 10.1111/1753-0407.70049.

本文引用的文献

1
Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study.基于 2 型糖尿病合并糖尿病肾病患者的前瞻性队列研究,推导并外部验证了一种用于估计心血管死亡未来风险的风险预测算法。
BMJ Open Diabetes Res Care. 2019 Nov 13;7(1):e000735. doi: 10.1136/bmjdrc-2019-000735. eCollection 2019.
2
Validation of clinical prediction models: what does the "calibration slope" really measure?临床预测模型的验证:“校准斜率”到底在衡量什么?
J Clin Epidemiol. 2020 Feb;118:93-99. doi: 10.1016/j.jclinepi.2019.09.016. Epub 2019 Oct 9.
3
Risk Prediction Scores for Mortality, Cerebrovascular, and Heart Disease Among Chinese People With Type 2 Diabetes.
中国 2 型糖尿病患者死亡、脑血管和心脏病风险预测评分。
J Clin Endocrinol Metab. 2019 Dec 1;104(12):5823-5830. doi: 10.1210/jc.2019-00731.
4
Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.死亡率、发病率和风险因素在中国及其省份,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2019 Sep 28;394(10204):1145-1158. doi: 10.1016/S0140-6736(19)30427-1. Epub 2019 Jun 24.
5
Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015.2006 年至 2015 年期间苏格兰有和无 2 型糖尿病患者的急性心肌梗死、心绞痛和冠状动脉血运重建发病率和病死率趋势。
Diabetologia. 2019 Mar;62(3):418-425. doi: 10.1007/s00125-018-4796-7. Epub 2019 Jan 17.
6
Analysis of treatment pathways for three chronic diseases using OMOP CDM.基于 OMOP CDM 分析三种慢性病的治疗路径。
J Med Syst. 2018 Nov 13;42(12):260. doi: 10.1007/s10916-018-1076-5.
7
Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.心血管疾病风险评分在诊断为 2 型糖尿病的人群中的表现:利用苏格兰国家糖尿病登记处的数据进行外部验证。
Diabetes Care. 2018 Sep;41(9):2010-2018. doi: 10.2337/dc18-0578. Epub 2018 Jul 12.
8
Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.使用美国多样化纵向队列的个体参与者数据验证 2 型糖尿病并发症风险方程(RECODe)
Diabetes Care. 2018 Mar;41(3):586-595. doi: 10.2337/dc17-2002. Epub 2017 Dec 21.
9
Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.基于人群的回顾性队列研究:为中国 2 型糖尿病患者开发心血管疾病风险预测模型和工具。
Diabetes Obes Metab. 2018 Feb;20(2):309-318. doi: 10.1111/dom.13066. Epub 2017 Aug 25.
10
Comparison of validation and application on various cardiovascular disease mortality risk prediction models in Chinese rural population.比较各种心血管疾病死亡风险预测模型在中国农村人群中的验证和应用。
Sci Rep. 2017 Mar 24;7:43227. doi: 10.1038/srep43227.